These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 36699022)

  • 1. Structural homology between 11 beta-hydroxysteroid dehydrogenase and
    Hernández-Bustamante I; Santander-Plantamura Y; Mata-Espinosa D; Reyes-Chaparro A; Bini EI; Torre-Villalvazo I; Tovar AR; Barrios-Payan J; Marquina-Castillo B; Hernández-Pando R; Carranza A
    Front Endocrinol (Lausanne); 2022; 13():1055430. PubMed ID: 36699022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 7α-hydroxylation of dehydroepiandrosterone does not interfere with the activation of glucocorticoids by 11β-hydroxysteroid dehydrogenase in E(t)C cerebellar neurons.
    Gottfried-Blackmore A; Jellinck PH; Vecchiarelli HA; Masheeb Z; Kaufmann M; McEwen BS; Bulloch K
    J Steroid Biochem Mol Biol; 2013 Nov; 138():290-7. PubMed ID: 23851218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dehydroepiandrosterone inhibits the amplification of glucocorticoid action in adipose tissue.
    Apostolova G; Schweizer RA; Balazs Z; Kostadinova RM; Odermatt A
    Am J Physiol Endocrinol Metab; 2005 May; 288(5):E957-64. PubMed ID: 15613680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In obese mice, exercise training increases 11β-HSD1 expression, contributing to glucocorticoid activation and suppression of pulmonary inflammation.
    Du SF; Yu Q; Chuan K; Ye CL; He ZJ; Liu SJ; Zhu XY; Liu YJ
    J Appl Physiol (1985); 2017 Oct; 123(4):717-727. PubMed ID: 28663379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dehydroepiandrosterone 7alpha-hydroxylation in human tissues: possible interference with type 1 11beta-hydroxysteroid dehydrogenase-mediated processes.
    Hennebert O; Chalbot S; Alran S; Morfin R
    J Steroid Biochem Mol Biol; 2007 May; 104(3-5):326-33. PubMed ID: 17467270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dehydroepiandrosterone exerts antiglucocorticoid action on human preadipocyte proliferation, differentiation, and glucose uptake.
    McNelis JC; Manolopoulos KN; Gathercole LL; Bujalska IJ; Stewart PM; Tomlinson JW; Arlt W
    Am J Physiol Endocrinol Metab; 2013 Nov; 305(9):E1134-44. PubMed ID: 24022868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative mechanism for anti-obesity effect of dehydroepiandrosterone: possible contribution of 11β-hydroxysteroid dehydrogenase type 1 inhibition in rodent adipose tissue.
    Tagawa N; Minamitani E; Yamaguchi Y; Kobayashi Y
    Steroids; 2011 Dec; 76(14):1546-53. PubMed ID: 21945397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 11beta-hydroxysteroid dehydrogenase type 1 inhibitors as promising therapeutic drugs for diabetes: status and development.
    Ge R; Huang Y; Liang G; Li X
    Curr Med Chem; 2010; 17(5):412-22. PubMed ID: 20015040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inter-conversion of 7alpha- and 7beta-hydroxy-dehydroepiandrosterone by the human 11beta-hydroxysteroid dehydrogenase type 1.
    Muller C; Pompon D; Urban P; Morfin R
    J Steroid Biochem Mol Biol; 2006 Jun; 99(4-5):215-22. PubMed ID: 16603347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hexose-6-phosphate dehydrogenase modulates 11beta-hydroxysteroid dehydrogenase type 1-dependent metabolism of 7-keto- and 7beta-hydroxy-neurosteroids.
    Nashev LG; Chandsawangbhuwana C; Balazs Z; Atanasov AG; Dick B; Frey FJ; Baker ME; Odermatt A
    PLoS One; 2007 Jun; 2(6):e561. PubMed ID: 17593962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of 11β-hydroxysteroid dehydrogenase 1 and 2 in patients with chronic rhinosinusitis and their possible contribution to local glucocorticoid activation in sinus mucosa.
    Jun YJ; Park SJ; Kim TH; Lee SH; Lee KJ; Hwang SM; Lee SH
    J Allergy Clin Immunol; 2014 Oct; 134(4):926-934.e6. PubMed ID: 24810847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)--a promising drug target for the treatment of metabolic syndrome.
    Masuzaki H; Flier JS
    Curr Drug Targets Immune Endocr Metabol Disord; 2003 Dec; 3(4):255-62. PubMed ID: 14683456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of 11β-hydroxysteroid dehydrogenase type 1 and 2 in nasal polyp-derived epithelial cells and its possible contribution to glucocorticoid activation in nasal polyp.
    Kook JH; Kim HJ; Kim KW; Park SJ; Kim TH; Lim SH; Kang SH; Lee SH
    Am J Rhinol Allergy; 2015; 29(4):246-50. PubMed ID: 26163245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hexose-6-phosphate dehydrogenase modulates the effect of inhibitors and alternative substrates of 11beta-hydroxysteroid dehydrogenase 1.
    Balázs Z; Nashev LG; Chandsawangbhuwana C; Baker ME; Odermatt A
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):117-22. PubMed ID: 19010388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 16α-Bromoepiandrosterone as a new candidate for experimental diabetes-tuberculosis co-morbidity treatment.
    López-Torres MO; Marquina-Castillo B; Ramos-Espinosa O; Mata-Espinosa D; Barrios-Payan JA; Baay-Guzman G; Yepez SH; Bini E; Torre-Villalvazo I; Torres N; Tovar A; Chamberlin W; Ge Y; Carranza A; Hernández-Pando R
    Clin Exp Immunol; 2021 Aug; 205(2):232-245. PubMed ID: 33866550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of 11β-hydroxysteroid dehydrogenase type 1 in antidiabetic therapy.
    Wang M
    Handb Exp Pharmacol; 2011; (203):127-46. PubMed ID: 21484570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addressing the role of 11β-hydroxysteroid dehydrogenase type 1 in the development of polycystic ovary syndrome and the putative therapeutic effects of its selective inhibition in a preclinical model.
    Li X; Hu S; Zhu Q; Yao G; Yao J; Li J; Wang Y; Ding Y; Qi J; Xu R; Zhao H; Zhu Z; Du Y; Sun K; Sun Y
    Metabolism; 2021 Jun; 119():154749. PubMed ID: 33722534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extra-adrenal regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1: physiological regulator and pharmacological target for energy partitioning.
    Walker BR
    Proc Nutr Soc; 2007 Feb; 66(1):1-8. PubMed ID: 17343766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased whole-body and sustained liver cortisol regeneration by 11beta-hydroxysteroid dehydrogenase type 1 in obese men with type 2 diabetes provides a target for enzyme inhibition.
    Stimson RH; Andrew R; McAvoy NC; Tripathi D; Hayes PC; Walker BR
    Diabetes; 2011 Mar; 60(3):720-5. PubMed ID: 21266326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 11β-HSD as a New Target in Pharmacotherapy of Metabolic Diseases.
    Kupczyk D; Bilski R; Kozakiewicz M; Studzińska R; Kędziora-Kornatowska K; Kosmalski T; Pedrycz-Wieczorska A; Głowacka M
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.